Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06522776
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers REPICOV-AKI
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of Brief Remote Psychological Intervention for COVID-19 Survivors With Acute Kidney Injury and Their Informal Primary Caregivers
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REPICOV-AKI
Brief Summary:
The frequency of psychological conditions in recovered COVID-19 patients with Acute Kidney Injury AKI and their informal primary caregivers IPC is unknown as well as the effects of psychological therapy in this population The present study was initiated to determine the effectiveness of a brief remote psychological intervention BRPI to reduce anxious and depressive symptoms in survivors of AKI
The investigator designed a single-case experimental design A-B with prospective follow-up We used the Patient Health Questionnaire-9 PHQ-9 and the General Anxiety Disorder Scale-7 GAD-7 to screen for depressive and anxiety symptoms one week later after hospital discharge Those with moderate or severe symptoms received cognitive behavioral therapy CBT and were evaluated over time with the instruments and daily self-report of symptoms The statistical analysis was conducted using statistical software
The investigator designed a single-case experimental design A-B with prospective follow-up We used the Patient Health Questionnaire-9 PHQ-9 and the General Anxiety Disorder Scale-7 GAD-7 to screen for depressive and anxiety symptoms one week later after hospital discharge Those with moderate or severe symptoms received cognitive behavioral therapy CBT and were evaluated over time with the instruments and daily self-report of symptoms The statistical analysis was conducted using statistical software
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None